Lincolnshire Institute of Cancer Researc - Dormant company accounts 11.6

Lincolnshire Institute of Cancer Researc - Dormant company accounts 11.6


06629083 1.12.13 30.11.14 30.11.14 Company accounts Private Limited Company FY true false true false false false true iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure066290832013-11-30066290832014-11-30066290832013-12-012014-11-30066290832012-11-30066290832012-12-012013-11-30066290832013-11-3006629083ns12:England2013-12-012014-11-3006629083ns14:PoundSterling2013-12-012014-11-3006629083ns7:Director12013-12-012014-11-3006629083ns7:Director22013-12-012014-11-3006629083ns7:Director32013-12-012014-11-3006629083ns7:RegisteredOffice2013-12-012014-11-30
REGISTERED NUMBER: 06629083 (England and Wales)















FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2014

FOR

LINCOLNSHIRE INSTITUTE OF CANCER
RESEARCH

LINCOLNSHIRE INSTITUTE OF CANCER
RESEARCH (REGISTERED NUMBER: 06629083)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2014




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3

LINCOLNSHIRE INSTITUTE OF CANCER
RESEARCH

COMPANY INFORMATION
FOR THE YEAR ENDED 30 NOVEMBER 2014







DIRECTORS: Professor O Eremin
Professor L G Walker
Doctor I Hindle





REGISTERED OFFICE: Research and Development Department
Lincoln County Hospital
Greetwell Road
Lincoln
LN2 5QY





REGISTERED NUMBER: 06629083 (England and Wales)

LINCOLNSHIRE INSTITUTE OF CANCER
RESEARCH (REGISTERED NUMBER: 06629083)

BALANCE SHEET
30 NOVEMBER 2014

2014 2013
£    £   
TOTAL ASSETS LESS CURRENT
LIABILITIES

-

-


RESERVES - -

The company is entitled to exemption from audit under Section 480 of the Companies Act 2006 for the year ended 30 November 2014.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2014 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its surplus or deficit for each financial year in accordance with the requirements of
Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to
financial statements, so far as applicable to the company.

These financial statements have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.


The financial statements were approved by the Board of Directors on 26 August 2015 and were signed on its behalf by:





Professor O Eremin - Director


LINCOLNSHIRE INSTITUTE OF CANCER
RESEARCH (REGISTERED NUMBER: 06629083)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2014

1. ACCOUNTING POLICIES

Accounting convention
The financial statements have been prepared under the historical cost convention and in accordance with the
Financial Reporting Standard for Smaller Entities (effective April 2008).

The company was dormant throughout the current year and previous year.